The symptom reported most frequently by PBC patients is chronic 2which is present in over 50%.

Unsurprisingly given its prevalence and lack of effective treatments, fatigue is frequently identified by PBC patients as the principal priority area for new therapy development.

  • RITPBC The trial is now closed to recruitment and on behalf of Prof Jones and the team we would like to thank all participants who volunteered, the study is still on-going and updates will be reported via the UK-PBC website.